-+ 0.00%
-+ 0.00%
-+ 0.00%
Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today
Share
Listen to the news

Wall Street slipped at midday Wednesday as a hotter-than-expected September inflation report stoked bets that the Federal Reserve will keep raising rates, with the Nasdaq 100 down 1.0% and semiconductors extending their losing streak to a seventh straight session.

Headline consumer prices rose 3.7% from a year earlier, above the 3.6% forecast and up from 3.4% in August, as gasoline prices jumped 7.1% on the month. Core CPI also came in above expectations at 2.6%.

Treasury yields climbed in response. The 2-year yield rose 14 basis points to 4.93%, while the 10-year gained 10 basis points to 5.31%, and the U.S. dollar index hit an 18-month high near 102.75.

Markets now assign a 45% chance of a further Fed rate hike at the Oct. 28 meeting.

White House economic adviser Kevin Hassett said earlier Wednesday that “this month’s core inflation was a blip,” adding that more data is needed before the Fed decides on rates.

Across U.S. equity markets by midday Wednesday, losses were concentrated in technology and rate-sensitive areas, while defensive health care names provided a cushion.

  • The S&P 500 fell 0.7% to 7,751
  • The Dow Jones Industrial Average slipped just 0.1%, or 46 points, to 51,624.

Gains in UnitedHealth Group Inc. (NYSE:UNH) (up 2.5%), Amgen Inc. (NASDAQ:AMGN) (up 3.2%) and Merck & Co. Inc. (NYSE:MRK) (up 2.2%) offset a 1.8% drop in Caterpillar Inc. (NYSE:CAT) and a 1.9% decline in Nvidia Corp. (NASDAQ:NVDA).

The Nasdaq 100 dropped 1.0% to 30,265. Within Magnificent Seven stocks, Meta Platforms Inc. (NASDAQ:META) fell 2.1%, Nvidia lost 1.9% and Tesla Inc. (NASDAQ:TSLA) slid 1.8%, while Apple Inc. (NASDAQ:AAPL) bucked the trend with a 1.1% gain.

In chips, Advanced Micro Devices Inc. (NASDAQ:AMD) sank 3.5%, Broadcom Inc. (NASDAQ:AVGO) fell 1.7% and Micron Technology Inc. (NASDAQ:MU) lost 1.6%. The small-cap Russell 2000 fell 1.3%.

Gold retreated as the stronger dollar and higher real yields weighed. The SPDR Gold Shares (NYSE:GLD) slid 1.7%, with gold futures down 1.4% near $4,119 an ounce and silver dropping 5.3% to about $56.36.

Wednesday’s Performance In Major US Indices

Index Last % Change MTD YTD
S&P 500 7,751.26 -0.69% +1.30% +13.23%
Dow Jones 51,624.28 -0.09% +1.41% +7.41%
Nasdaq 100 30,264.81 -1.00% -0.47% +19.86%
Russell 2000 2,746.87 -1.31% -1.79% +10.68%
Updated by 11:06 AM ET

According to the Benzinga Pro platform:

  • The Vanguard S&P 500 ETF (NYSE:VOO) fell 0.7%.
  • The SPDR Dow Jones Industrial Average ETF Trust (NYSE:DIA) slipped 0.1%.
  • The Invesco QQQ Trust (NASDAQ:QQQ) declined 1.0%.
  • The iShares Russell 2000 ETF (NYSE:IWM) dropped 1.3%.

Health Care Stands Alone As Chips, Gold Miners And AI Infrastructure Sell Off

Among S&P 500 sectors, the Health Care Select Sector SPDR Fund (NYSE:XLV) led with a 1.6% gain. The Consumer Staples Select Sector SPDR Fund (NYSE:XLP) rose 0.7% and the Energy Select Sector SPDR Fund (NYSE:XLE) added 0.2%.

The Technology Select Sector SPDR Fund (NYSE:XLK) was the weakest, down 1.6%.

The Financial Select Sector SPDR Fund (NYSE:XLF) and the Utilities Select Sector SPDR Fund (NYSE:XLU) each lost 1.3%, while the Real Estate Select Sector SPDR Fund (NYSE:XLRE) and the Consumer Discretionary Select Sector SPDR Fund (NYSE:XLY) fell 1.2%.

The Communication Services Select Sector SPDR Fund (NYSE:XLC) and the Industrials Select Sector SPDR Fund (NYSE:XLI) each slid 1.0%, and the Materials Select Sector SPDR Fund (NYSE:XLB) lost 0.8%.

Among industry funds, the VanEck Gold Miners ETF (NYSE:GDX) tumbled 4.0% alongside bullion, and the iShares U.S. Home Construction ETF (BATS:ITB) dropped 2.7% as mortgage-sensitive stocks reacted to higher yields.

The iShares Semiconductor ETF (NASDAQ:SOXX) fell 2.3% for a seventh straight session, leaving it nearly 10% below its Oct. 5 close, while the VanEck Semiconductor ETF (NASDAQ:SMH) lost 2.2%.

On the Upside

The iShares Biotechnology ETF (NASDAQ:IBB) rose 1.3%.

In Russell 1000 gainers, the bid was led by drug and biotech names. 

Halozyme Therapeutics Inc. (NASDAQ:HALO) jumped 7.2% and Eli Lilly and Co. (NYSE:LLY) gained 3.4%, with Amgen adding 3.2% and AbbVie Inc. (NYSE:ABBV) up 3.0%.

The moves look like a sector-wide rotation into defensives. 

GlobalFoundries Inc. (NASDAQ:GFS) rose 5.0% after it was selected to operate two new semiconductor fabs in New York under a U.S.-Japan initiative, according to a company press release. Caris Life Sciences Inc. (NASDAQ:CAI) climbed 4.8%.

On the Downside

AI infrastructure financing names were hit hardest. 

CoreWeave Inc. (NASDAQ:CRWV) plunged 13.8% as a bond yield touching 15% and a “Yikes” reaction from Elon Musk weighed on the stock. 

TeraWulf Inc. (NASDAQ:WULF) fell 9.3% and DigitalOcean Holdings Inc. (NYSE:DOCN) dropped 10.0%, trading in sympathy with CoreWeave and other neocloud peers such as IREN Ltd. (NASDAQ:IREN), which lost 8.5%. 

Fermi Inc. (NASDAQ:FRMI) sank 9.3%, giving back part of Tuesday’s 14% surge on AMD credit support for its Project Matador.

Affirm Holdings Inc. (NASDAQ:AFRM) slid 9.2 as rate-sensitive fintechs sold off, with SoFi Technologies Inc. (NASDAQ:SOFI) down 6.2% and Robinhood Markets Inc. (NASDAQ:HOOD) off 6.2%.

Elsewhere, Dell Technologies Inc. (NYSE:DELL) fell 8.2% and Oracle Corp. (NYSE:ORCL) lost 6.5%, while Bank of America Corp. (NYSE:BAC) dropped 7.7% after a $1.2 billion money-laundering penalty drove an earnings miss.

Wednesday’s Russell 1000 Top Gainers

Name % change
Halozyme Therapeutics, Inc. +7.22%
GLOBALFOUNDRIES Inc. +5.00%
Caris Life Sciences, Inc. +4.76%
Eli Lilly and Company +3.36%
Amgen Inc. +3.19%

Wednesday’s Russell 1000 Top Losers

Name % change
CoreWeave, Inc. -13.82%
DigitalOcean Holdings, Inc. -9.96%
TeraWulf Inc. -9.33%
Fermi Inc. -9.27%
Affirm Holdings, Inc. -9.20%

Image: Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending